Vitamin C Trial Links Supplement Use to Fewer Deaths in Blood Disorders
A phase 2 trial found daily vitamin C did not slow abnormal blood cell growth, but it was linked to fewer deaths in low-risk blood cancers.
Trials, guidelines and clinical evidence across Hematology.
Trials, guidelines and clinical evidence across Hematology.